This project looks at innovative ways to expand the services the industry partner offers and to innovate for the needs of the community. It will be it approached looking at the best way to expand the scope of services they offer that conform with pharmaceutical standards and industry regulations.

Our abdomen can contract in order to help us breath. Restricting our abdomen has previously shown to reduce the function of our lungs at rest, and change the way we breath during exercise. Women’s athletic apparel has trended towards high-waisted, lower body garments. A high-waisted band, although not as severe as abdominal strapping, can apply […]

Women use sports bras to reduce the breast movement and discomfort during exercise. In order to provide support, sports bras have a tight fit, adding pressure to rib cage. Pressure applied to the rib cage via a sports bra, can provide resistance during inspiration, and increasing the effort and work required to breath. The purpose […]

Neuractas Therapeutics is a Canadian pharmaceutical company that is developing novel agents for neurological indications. Neuractas has developed neur-04 for epilepsy, this agent is a reformulation of an existing drug that has demonstrated strong clinical anticonvulsant activity in the most difficult-to-treat cases of epilepsy. Often people with epilepsy have to try several different medications before […]

There is a health crisis in Canada where substance abuse and addiction disorders have been growing out of control, resulting in the death of 19,355 Canadians from 2016 to 2020. Researchers describe the crisis to be getting worse in that opioid-related deaths tripled from 2000 to 2015 in Ontario, Canada and increased by 120% since […]

Atlantic Assisted Reproduction Therapies (AART) is the primary facility located in the Atlantic Provinces capable of assisting reproductively challenged couples. Fertility Pharmacy Services(FPS) is an onsite subsidiary of AART. AART offers a wide range of services, however, AART currently does not have the capacity to assist individuals who require preimplantation genetic testing. Clients who require […]

Sujet du stage : L’étudiant effectuera un stage de recherche portant sur l’exploration de l’adéquation des besoins exprimés par les personnes vivant avec de la douleur chronique face aux soins de physiothérapie et les politiques cliniques et organisationnels des milieux de soins privés et publics de physiothérapie au Québec. Des soins éthiques reposent sur la […]

Ce projet vise à mesurer, d’une part, la faisabilité et l’acceptabilité d’un programme d’activité physique faisant appel à une gérontechnologie auprès des aînés vivant en résidence pour personnes âgées et, d’autre part, les bénéfices d’une telle d’intervention auprès de cette population. Nous faisons appel à une technologie adaptée appelée Jintronix qui offre une variété d’activités […]

Les mycotoxines contaminent principalement les céréales au champ ou au cours de leur stockage. Elles sont toxiques pour l’homme et les animaux. Avec plus de 56% d’échantillons testés positifs en alimentation animale, la zéaralenone est la mycotoxine la plus présente en Amérique du Nord après le déoxynivalenol. La présence de cette mycotoxine dans l’alimentation, même […]

Plant-based beverages, originally introduced as cow milk alternatives, have attracted great attention from consumers in recent years due to their sustainability and health benefits. Oat beverages has become one of the most successful commercial products in the Canadian market due to the large oat production, high protein and dietary fiber contents and excellent sensory property. […]

The boreal mixedwood forests of the Abitibi region of Quebec are often characterized by a canopy of trembling aspen with shade tolerant species such as white spruce and balsam fir in the subcanopy. In many cases, harvesting has converted complex mixedwoods into simpler, even aged forests. Due to the differences in regeneration and tree growth, […]

Pharma in silica is a preclinical stage company developing silica-based nanoparticles to formulate more efficient and better tolerated chemotherapy modalities. In this collaboration, they will benefit from the expertise of the laboratories of Prof N. Bertrand and S. Fortin to obtain useful chemistry, manufacturing, and control (CMC) information and advance their nanoparticles toward regulatory approval. […]